Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (258)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MCOMBE, P. A.
Right arrow Articles by MCLEOD, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MCOMBE, P. A.
Right arrow Articles by MCLEOD, J. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 110, No. 6, 1617-1630, 1987
© 1987 Guarantors of Brain


research-article

CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY

A CLINICAL AND ELECTROPHYSIOLOGICAL STUDY OF 92 CASES

P. A. MCOMBE, J. D. POLLARD and J. G. MCLEOD

Department of Medicine, University of Sydney Australia

Correspondence to: Professor J. G. McLeod, Department of Medicine, University of Sydney NSW 2006, Australia

Ninety-two patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been studied in order to define better the clinical features, course and prognosis of the condition and to identify possible aetiological factors. Sural nerve biopsy was performed on 87 subjects. Electrophysiological studies were undertaken on all patients and demonstrated marked slowing of motor conduction and impairment of sensory conduction. The onset was usually gradual but there was a rapid rate of onset in 15 (16%) patients. Males were more commonly affected than females. Weakness and paraesthesiae were the most common symptoms but pain was frequently a feature. Age of onset ranged from 2 to 72 years. Sixty patients (65%) had a relapsing course and 32 patients (35%) a progressive or monophasic course; there was a significantly earlier age of onset in patients with relapsing disease. Thirty-two patients (35%) gave a history of preceding infection or some other possible antecedent precipitating event and there was a significantly higher titre for cytomegalovirus antibodies in the serum of patients with CIDP than in controls. The patients were followed up for an average time of approximately ten years. Most patients (73%) had made a good recovery and were independent, but 7 patients had either died or were completely immobilized as a result of their disease. The value of treatment with corticosteroid therapy, immunosuppressive agents and plasma exchange is discussed.

Received December 9, 1986. Revised March 12, 1987. Accepted March 23, 1987.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
M P T Lunn and H J Willison
Diagnosis and treatment in inflammatory neuropathies
Postgrad. Med. J., August 1, 2009; 85(1006): 437 - 446.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M P T Lunn and H J Willison
Diagnosis and treatment in inflammatory neuropathies
J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 249 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Kuitwaard, R van Koningsveld, L Ruts, B C Jacobs, and P A van Doorn
Recurrent Guillain-Barre syndrome
J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 56 - 59.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. A. Muley, P. Kelkar, and G. J. Parry
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With Pulsed Oral Steroids
Arch Neurol, November 1, 2008; 65(11): 1460 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
The French CIDP Study Group
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
Postgrad. Med. J., July 1, 2008; 84(993): 378 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
The French CIDP Study Group
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 115 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Chio, D Cocito, E Bottacchi, C Buffa, M Leone, F Plano, R Mutani, A Calvo, and the PARCIDP
Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1349 - 1353.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Oyama, R. Sufit, Y. Loh, L. Statkute, K. Yaung, K. Quigley, E. Gonda, D. Spahovic, D. Bronesky, and R. K. Burt
NONMYELOABLATIVE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CIDP
Neurology, October 30, 2007; 69(18): 1802 - 1803.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H R Inglis, P A Csurhes, and P A McCombe
Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 419 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Kuwabara, S Misawa, M Mori, N Tamura, M Kubota, and T Hattori
Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 66 - 70.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Ruts, R. van Koningsveld, and P. A. van Doorn
Distinguishing acute-onset CIDP from Guillain-Barre syndrome with treatment related fluctuations
Neurology, July 12, 2005; 65(1): 138 - 140.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Lopate, A. Pestronk, and M. Al-Lozi
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone
Arch Neurol, February 1, 2005; 62(2): 249 - 254.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. V. Toyka and R. Gold
The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents
Neurology, April 22, 2003; 60(90083): S2 - 7.
[Abstract] [Full Text]


Home page
NeurologyHome page
A. H. Ropper
Current treatments for CIDP
Neurology, April 22, 2003; 60(90083): S16 - 22.
[Abstract] [Full Text]


Home page
NEJMHome page
H. W. Sander and E. T. Hedley-Whyte
Case 6-2003 - A Nine-Year-Old Girl with Progressive Weakness and Areflexia
N. Engl. J. Med., February 20, 2003; 348(8): 735 - 743.
[Full Text] [PDF]


Home page
NeurologyHome page
B. C. Kieseier, M. C. Dalakas, and H.-P. Hartung
Immune mechanisms in chronic inflammatory demyelinating neuropathy
Neurology, December 24, 2002; 59(90126): S7 - 12.
[Abstract] [Full Text]


Home page
NeurologyHome page
K. Mori, N. Hattori, M. Sugiura, H. Koike, K. Misu, M. Ichimura, M. Hirayama, and G. Sobue
Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS
Neurology, March 26, 2002; 58(6): 979 - 982.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Kuwabara, K Ogawara, S Misawa, M Mori, and T Hattori
Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy
J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Vermeulen and M H Van Oers
Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy
J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 127 - 128.
[Full Text] [PDF]


Home page
BrainHome page
W. M. J. Bosboom, L. H. van den Berg, H. Franssen, P. C. L. M. Giesbergen, H. Z. Flach, A. M. van Putten, H. Veldman, and J. H. J. Wokke
Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy
Brain, December 1, 2001; 124(12): 2427 - 2438.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Misawa, S. Kuwabara, M. Mori, N. Kawaguchi, Y. Yoshiyama, and T. Hattori
Serum levels of tumor necrosis factor-{{alpha}} in chronic inflammatory demyelinating polyneuropathy
Neurology, March 13, 2001; 56(5): 666 - 669.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J.R. Mendell, R.J. Barohn, M.L. Freimer, J.T. Kissel, W. King, H.N. Nagaraja, R. Rice, W.W. Campbell, P.D. Donofrio, C.E. Jackson, et al.
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy
Neurology, February 27, 2001; 56(4): 445 - 449.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W.M.J. Bosboom, L.H. Van den Berg, I. Mollee;, L.D. Sasker;, J. Jansen, J.H.J. Wokke, and T. Logtenberg
Sural nerve T-cell receptor V{beta} gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy
Neurology, January 9, 2001; 56(1): 74 - 81.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. U. Haq, T. J. Fries, W. W. Pendlebury, M. J. Kenny, G. J. Badger, and R. Tandan
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Study of Proposed Electrodiagnostic and Histologic Criteria
Arch Neurol, December 1, 2000; 57(12): 1745 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Hara, K. Minami, K. Takamoto, M. Shiraishi, and T. Sata
The Prolonged Effect of a Muscle Relaxant in a Patient with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Anesth. Analg., January 1, 2000; 90(1): 224 - 224.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Duarte, A C. Martinez, F Rodriguez, A Mendoza, A P Sempere, and L E Claveria
Hypertrophy of multiple cranial nerves and spinal roots in chronic inflammatory demyelinating neuropathy
J. Neurol. Neurosurg. Psychiatry, November 1, 1999; 67(5): 685 - 687.
[Full Text]


Home page
Nephrol Dial TransplantHome page
E. F. de Maar, D. M. Kas-Deelen, A. E. J. de Jager, H. The, A. M. Tegzess, and W. J. van Son
Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection
Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2228 - 2230.
[Full Text] [PDF]


Home page
NeurologyHome page
W. M. J. Bosboom, L. H. Van den Berg, L. De Boer, M. J. Van Son, H. Veldman, H. Franssen, T. Logtenberg, and J. H. J. Wokke
The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy
Neurology, September 1, 1999; 53(4): 837 - 837.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. D. M. Hadden, B. Sharrack, S. Bensa, S. E. Soudain, and R. A. C. Hughes
Randomized trial of interferon {beta}-1a in chronic inflammatory demyelinating polyradiculoneuropathy
Neurology, July 1, 1999; 53(1): 57 - 57.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M P T Lunn, H Manji, P P Choudhary, R A C Hughes, and P K Thomas
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England
J. Neurol. Neurosurg. Psychiatry, May 1, 1999; 66(5): 677 - 680.
[Abstract] [Full Text]


Home page
NeurologyHome page
C. Bouchard, C. Lacroix, V. Plante, D. Adams, F. Chedru, J.-M. Guglielmi, and G. Said
Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy
Neurology, February 1, 1999; 52(3): 498 - 498.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
K. North
NEW PERSPECTIVES IN PEDIATRIC NEUROMUSCULAR DISORDERS Hotel Intercontinental Sydney, Sydney, Australia, August 28, 1998
J Child Neurol, January 1, 1999; 14(1): 26 - 57.
[PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D S M Molenaar, M Vermeulen, and R de Haan
Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy
J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 84 - 89.
[Abstract] [Full Text]


Home page
Mult SclerHome page
G. Comi, R. Nemni, S. Amadio, G. Galardi, and L. Leocani
Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies
Multiple Sclerosis, April 1, 1997; 3(2): 93 - 97.
[Abstract] [PDF]


Home page
NEJMHome page
D. Weinberg and E. J. Mark
Case 32-1994- A 61-Year-Old Man with Muscular Weakness
N. Engl. J. Med., August 25, 1994; 331(8): 528 - 535.
[Full Text]


Home page
Arch NeurolHome page
R. Hughes, E. Sanders, S. Hall, P. Atkinson, A. Colchester, and P. Payan
Subacute Idiopathic Demyelinating Polyradiculoneuropathy
Arch Neurol, June 1, 1992; 49(6): 612 - 616.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. M. Shefner and D. M. Dawson
The Use of Sensory Action Potentials in the Diagnosis of Peripheral Nerve Disease
Arch Neurol, March 1, 1990; 47(3): 341 - 348.
[Abstract] [PDF]


Home page
Arch NeurolHome page
E. F. M. Wijdicks and A. H. Ropper
Acute Relapsing Guillain-Barre Syndrome After Long Asymptomatic Intervals
Arch Neurol, January 1, 1990; 47(1): 82 - 84.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. J. Barohn, J. T. Kissel, J. R. Warmolts, and J. R. Mendell
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Clinical Characteristics, Course, and Recommendations for Diagnostic Criteria
Arch Neurol, August 1, 1989; 46(8): 878 - 884.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.